MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 25.02.2026
Arcus Biosciences PEG 2011-2026 | RCUS
PEG Jährlich Arcus Biosciences
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0441 | 0.0242 | 0.0313 | - | 0.397 | 0.02 | -0.0399 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.397 | -0.0399 | 0.0794 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Assembly Biosciences
ASMB
|
-0.453 | $ 28.49 | 0.11 % | $ 319 M |  USA |
 |
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 19.61 | 0.59 % | $ 917 M | USA |
 |
Amarin Corporation plc
AMRN
|
0.635 | $ 14.72 | 1.59 % | $ 6.11 B |  Irlanda |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Ascendis Pharma A/S
ASND
|
-0.767 | $ 221.08 | -0.36 % | $ 5 B |  Danmark |
 |
Autolus Therapeutics plc
AUTL
|
0.0906 | $ 1.4 | 1.82 % | $ 357 M |  Britain |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Axsome Therapeutics
AXSM
|
-5.2 | $ 155.38 | -0.98 % | $ 7.73 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | USA |
 |
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Acer Therapeutics
ACER
|
0.0443 | - | 2.71 % | $ 14 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
0.177 | $ 55.05 | 1.7 % | $ 10.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M |  Israel |
 |
AbCellera Biologics
ABCL
|
0.0142 | $ 3.46 | 1.76 % | $ 1.03 B | Canada |
 |
Benitec Biopharma
BNTC
|
-0.358 | $ 10.92 | -0.55 % | $ 449 M | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
-1.33 | - | -10.95 % | $ 876 K | USA |
 |
Cara Therapeutics
CARA
|
0.00142 | - | -3.03 % | $ 260 M | USA |
 |
ChemoCentryx
CCXI
|
-0 | - | - | $ 3.74 B | USA |
 |
Heron Therapeutics
HRTX
|
-0.000562 | $ 0.79 | 2.02 % | $ 132 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
0.0308 | - | -74.18 % | $ 955 K | USA |
 |
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | USA |
 |
Clovis Oncology
CLVS
|
0.0458 | - | -7.23 % | $ 13 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Compugen Ltd.
CGEN
|
0.0951 | $ 2.13 | 2.15 % | $ 199 M | Israel |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.58 | 3.62 % | $ 185 M | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
0.408 | $ 4.47 | 5.54 % | $ 742 M | Canada |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000777 | - | 1.93 % | $ 17.4 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.0018 | - | -5.98 % | $ 34.1 M | USA |